Pharmaceutical industry raised R&D investment to 5%.

Published: 2006-01-03 06:58:00
Updated: 2006-01-03 06:58:00
The Korean pharmaceutical industry has raised an ongoing investment rate for the R&D-to-sales according to the KPMA report.

The report indicated that the total sales of 37 listed drug companies in 2004 amounted to 5,045,400 million won, 5% (254,100 million won) of which was spent for the R&D. ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.